Global Peptides Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Peptides Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Peptides Market Size Growth Rate by Product
  • 1.4.2 Insulin
  • 1.4.3 Teriparatide
  • 1.4.4 Liraglutide
  • 1.4.5 Leuprolide
• 1.5 Market by End User
  • 1.5.1 Global Peptides Market Size Growth Rate by End User
  • 1.5.2 Diabetes
  • 1.5.3 Infectious Diseases
  • 1.5.4 Cancer
  • 1.5.5 Osteoporosis
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Peptides Market Size
  • 2.1.1 Global Peptides Revenue 2014-2025
  • 2.1.2 Global Peptides Sales 2014-2025
• 2.2 Peptides Growth Rate by Regions
  • 2.2.1 Global Peptides Sales by Regions
  • 2.2.2 Global Peptides Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Peptides Sales by Manufacturers
  • 3.1.1 Peptides Sales by Manufacturers
  • 3.1.2 Peptides Sales Market Share by Manufacturers
  • 3.1.3 Global Peptides Market Concentration Ratio (CR5 and HHI)
• 3.2 Peptides Revenue by Manufacturers
  • 3.2.1 Peptides Revenue by Manufacturers (2014-2019)
  • 3.2.2 Peptides Revenue Share by Manufacturers (2014-2019)
• 3.3 Peptides Price by Manufacturers
• 3.4 Peptides Manufacturing Base Distribution, Product Types
  • 3.4.1 Peptides Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Peptides Product Type
  • 3.4.3 Date of International Manufacturers Enter into Peptides Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Peptides Sales by Product
• 4.2 Global Peptides Revenue by Product
• 4.3 Peptides Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Peptides Breakdown Data by End User

6 North America

• 6.1 North America Peptides by Countries
  • 6.1.1 North America Peptides Sales by Countries
  • 6.1.2 North America Peptides Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Peptides by Product
• 6.3 North America Peptides by End User

7 Europe

• 7.1 Europe Peptides by Countries
  • 7.1.1 Europe Peptides Sales by Countries
  • 7.1.2 Europe Peptides Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Peptides by Product
• 7.3 Europe Peptides by End User

8 Asia Pacific

• 8.1 Asia Pacific Peptides by Countries
  • 8.1.1 Asia Pacific Peptides Sales by Countries
  • 8.1.2 Asia Pacific Peptides Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Peptides by Product
• 8.3 Asia Pacific Peptides by End User

9 Central & South America

• 9.1 Central & South America Peptides by Countries
  • 9.1.1 Central & South America Peptides Sales by Countries
  • 9.1.2 Central & South America Peptides Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Peptides by Product
• 9.3 Central & South America Peptides by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Peptides by Countries
  • 10.1.1 Middle East and Africa Peptides Sales by Countries
  • 10.1.2 Middle East and Africa Peptides Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Peptides by Product
• 10.3 Middle East and Africa Peptides by End User

11 Company Profiles

• 11.1 Cipla Ltd.
  • 11.1.1 Cipla Ltd. Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Cipla Ltd. Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Cipla Ltd. Peptides Products Offered
  • 11.1.5 Cipla Ltd. Recent Development
• 11.2 Emcure Pharmaceuticals Pvt. Ltd.
  • 11.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Products Offered
  • 11.2.5 Emcure Pharmaceuticals Pvt. Ltd. Recent Development
• 11.3 Gland Pharma Limited
  • 11.3.1 Gland Pharma Limited Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Gland Pharma Limited Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Gland Pharma Limited Peptides Products Offered
  • 11.3.5 Gland Pharma Limited Recent Development
• 11.4 Troikaa Pharmaceuticals Ltd.
  • 11.4.1 Troikaa Pharmaceuticals Ltd. Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Troikaa Pharmaceuticals Ltd. Peptides Products Offered
  • 11.4.5 Troikaa Pharmaceuticals Ltd. Recent Development
• 11.5 Biological E Limited
  • 11.5.1 Biological E Limited Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Biological E Limited Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Biological E Limited Peptides Products Offered
  • 11.5.5 Biological E Limited Recent Development
• 11.6 Bharat Biotech
  • 11.6.1 Bharat Biotech Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Bharat Biotech Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Bharat Biotech Peptides Products Offered
  • 11.6.5 Bharat Biotech Recent Development
• 11.7 Samarth Life Sciences Pvt. Ltd.
  • 11.7.1 Samarth Life Sciences Pvt. Ltd. Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Products Offered
  • 11.7.5 Samarth Life Sciences Pvt. Ltd. Recent Development
• 11.8 VHB Life Sciences Limited
  • 11.8.1 VHB Life Sciences Limited Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 VHB Life Sciences Limited Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 VHB Life Sciences Limited Peptides Products Offered
  • 11.8.5 VHB Life Sciences Limited Recent Development
• 11.9 Celon Laboratories Pvt. Ltd.
  • 11.9.1 Celon Laboratories Pvt. Ltd. Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Celon Laboratories Pvt. Ltd. Peptides Products Offered
  • 11.9.5 Celon Laboratories Pvt. Ltd. Recent Development
• 11.10 United Biotech (P) Limited
  • 11.10.1 United Biotech (P) Limited Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 United Biotech (P) Limited Peptides Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 United Biotech (P) Limited Peptides Products Offered
  • 11.10.5 United Biotech (P) Limited Recent Development

12 Future Forecast

• 12.1 Peptides Market Forecast by Regions
  • 12.1.1 Global Peptides Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Peptides Revenue Forecast by Regions 2019-2025
• 12.2 Peptides Market Forecast by Product
  • 12.2.1 Global Peptides Sales Forecast by Product 2019-2025
  • 12.2.2 Global Peptides Revenue Forecast by Product 2019-2025
• 12.3 Peptides Market Forecast by End User
• 12.4 North America Peptides Forecast
• 12.5 Europe Peptides Forecast
• 12.6 Asia Pacific Peptides Forecast
• 12.7 Central & South America Peptides Forecast
• 12.8 Middle East and Africa Peptides Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Peptides Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details